ProShare Advisors’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $990K | Sell |
1,870
-333
| -15% | -$154K | ﹤0.01% | 808 |
|
|
2026
Q1 | $1.06M | Buy |
2,203
+32
| +1% | +$16.4K | ﹤0.01% | 780 |
|
|
2025
Q4 | $1.22M | Buy |
2,171
+166
| +8% | +$94.2K | ﹤0.01% | 775 |
|
|
2025
Q3 | $1.03M | Sell |
2,005
-183
| -8% | -$79.9K | ﹤0.01% | 805 |
|
|
2025
Q2 | $687K | Sell |
2,188
-294
| -12% | -$88.3K | ﹤0.01% | 956 |
|
|
2025
Q1 | $756K | Sell |
2,482
-226
| -8% | -$76K | ﹤0.01% | 904 |
|
|
2024
Q4 | $900K | Sell |
2,708
-278
| -9% | -$94.3K | ﹤0.01% | 965 |
|
|
2024
Q3 | $997K | Sell |
2,986
-82
| -3% | -$31.2K | ﹤0.01% | 812 |
|
|
2024
Q2 | $1.26M | Sell |
3,068
-269
| -8% | -$107K | ﹤0.01% | 722 |
|
|
2024
Q1 | $1.35M | Buy |
3,337
+101
| +3% | +$35.5K | ﹤0.01% | 729 |
|
|
2023
Q4 | $992K | Sell |
3,236
-54
| -2% | -$14.6K | ﹤0.01% | 758 |
|
|
2023
Q3 | $797K | Sell |
3,290
-169
| -5% | -$43.2K | ﹤0.01% | 766 |
|
|
2023
Q2 | $831K | Sell |
3,459
-3,271
| -49% | -$679K | ﹤0.01% | 763 |
|
|
2023
Q1 | $1.27M | Sell |
6,730
-1,041
| -13% | -$215K | ﹤0.01% | 697 |
|
|
2022
Q4 | $1.65M | Buy |
7,771
+596
| +8% | +$119K | 0.01% | 651 |
|
|
2022
Q3 | $1.13M | Sell |
7,175
-462
| -6% | -$73.7K | ﹤0.01% | 713 |
|
|
2022
Q2 | $1.14M | Sell |
7,637
-4,306
| -36% | -$623K | ﹤0.01% | 737 |
|
|
2022
Q1 | $1.95M | Sell |
11,943
-2,774
| -19% | -$457K | ﹤0.01% | 720 |
|
|
2021
Q4 | $3.2M | Buy |
14,717
+693
| +5% | +$145K | 0.01% | 665 |
|
|
2021
Q3 | $2.65M | Sell |
14,024
-2,054
| -13% | -$375K | 0.01% | 655 |
|
|
2021
Q2 | $2.84M | Buy |
16,078
+1,638
| +11% | +$283K | 0.01% | 646 |
|
|
2021
Q1 | $2.37M | Buy |
14,440
+649
| +5% | +$99.3K | 0.01% | 650 |
|
|
2020
Q4 | $1.92M | Buy |
13,791
+2,895
| +27% | +$365K | 0.01% | 644 |
|
|
2020
Q3 | $1.22M | Buy |
10,896
+1,084
| +11% | +$125K | 0.01% | 667 |
|
|
2020
Q2 | $913K | Buy |
9,812
+2,789
| +40% | +$237K | ﹤0.01% | 738 |
|
|
2020
Q1 | $515K | Sell |
7,023
-5,262
| -43% | -$457K | ﹤0.01% | 728 |
|
|
2019
Q4 | $1.03M | Sell |
12,285
-1,263
| -9% | -$97.8K | ﹤0.01% | 788 |
|
|
2019
Q3 | $1.14M | Buy |
13,548
+41
| +0.3% | +$3.1K | 0.01% | 712 |
|
|
2019
Q2 | $884K | Sell |
13,507
-1,729
| -11% | -$99.6K | 0.01% | 800 |
|
|
2019
Q1 | $898K | Buy |
15,236
+876
| +6% | +$52.3K | 0.01% | 814 |
|
|
2018
Q4 | $760K | Sell |
14,360
-2,804
| -16% | -$154K | 0.01% | 792 |
|
|
2018
Q3 | $1.03M | Buy |
17,164
+674
| +4% | +$36.9K | 0.01% | 810 |
|
|
2018
Q2 | $709K | Sell |
16,490
-1,121
| -6% | -$45.3K | ﹤0.01% | 967 |
|
|
2018
Q1 | $615K | Sell |
17,611
-3,659
| -17% | -$134K | ﹤0.01% | 1024 |
|
|
2017
Q4 | $771K | Buy |
+21,270
| New | +$746K | 0.01% | 939 |
|
Other funds holding MEDP
WA
ProShare Advisors's MEDP Position: Q2 2026 in Review
ProShare Advisors reduced its Medpace (MEDP) stake by 15% in Q2 2026, selling an estimated $154K and leaving 1,870 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #808.
ProShare Advisors first reported a position in MEDP in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.2M in Q4 2021. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- ProShare Advisors held 1,870 shares of Medpace worth $990K as of Q2 2026.
- ProShare Advisors sold 333 Medpace shares in Q2 2026, an estimated $154K.
- Medpace made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #808 holding.
- ProShare Advisors first reported a position in Medpace in Q4 2017 and has held it in 35 quarters since.
- ProShare Advisors's Medpace position peaked at $3.2M in Q4 2021.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.